| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |